Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1(+) Subsets in Mouse Immunocompetent Models

Oncolytic virotherapy uses viruses designed to selectively replicate in cancer cells. An alternative to intratumoral administration is to use mesenchymal stem cells (MSCs) to transport the oncolytic viruses to the tumor site. Following this strategy, our group has already applied this treatment to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales-Molina, Alvaro, Rodríguez-Milla, Miguel Ángel, Gimenez-Sanchez, Alicia, Perisé-Barrios, Ana Judith, García-Castro, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409201/
https://www.ncbi.nlm.nih.gov/pubmed/32708639
http://dx.doi.org/10.3390/cancers12071920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409201/
https://www.ncbi.nlm.nih.gov/pubmed/32708639
http://dx.doi.org/10.3390/cancers12071920

Ejemplares similares